Skip to main content
Fax No
N/A
Email:
amanyamro194@yahoo.com
MIS Email
dr_amanymohamed@aun.edu.eg
Mobile
01065658323/010
Office
N/A - 04252
Google Scholar

M.D. In () , , 2007


Professor South Egypt Cancer Institute, ِِAssiut University , 2017

Associate Professor South Egypt Cancer Institute, Assiut University , 2013

Lecturer South Egypt Cancer Institute, Assiut University , 2007

Assistant Lecturer South Egypt Cancer Institute, Assiut University , 2001


Head South Egypt Cancer Institute, Assiut University ,since 2013-08-01

# Title Research Year
1 Detection of Epstein-Barr virus Latent Membrane Protein-1 in Pediatric Lymphoma: A Report from South Egypt Cancer Institute 2022
2 Clinicolaboratory Characteristics and Outcome of Pediatric Acute Lymphoblastic Leukemia in a Resource-Limited Setting: A Study from South Egypt 2022
3 Malnutrition Assessment in Pediatric Acute Lymphoblastic Leukemia in Upper Egypt and Its Effect on Induction Response 2022
4 Clinical Outcome of Pediatric Acute Myeloid Leukemia Treated at South Egypt Cancer Institute, Assiut University, Egypt 2021
5 Clinical Outcome of Pediatric Acute Myeloid Leukemia Treated at South Egypt Cancer Institute, Assiut University, Egypt 2021
6 Pattern of Pediatric Soft Tissue and Bone Sarcomas at South
Egypt Cancer Institute, Retrospective Study
2021
7 Long term survival outcome of childhood acute lymphoblastic leukemia treated with modified TXIIIB protocol at South Egypt Cancer Institute 2021
8 Pattern of Pediatric Soft Tissue and Bone Sarcomas at South
Egypt Cancer Institute, Retrospective Study
2021
9 Long term survival outcome of childhood acute lymphoblastic leukemia treated with modified TXIIIB protocol at South Egypt Cancer Institute 2021
10 Neutropenic enterocolitis in pediatric leukemia patients treated with intensive chemotherapy in Upper Egypt 2020
11 Risk-Adapted, Combined-Modality Therapy for
Unfavorable Pediatric Hodgkin Lymphom
2018
12 Risk-Adapted, Combined-Modality Therapy for Unfavorable Pediatric Hodgkin Lymphom
2018
13 Risk-Adapted, Combined-Modality Therapy for Unfavorable Pediatric Hodgkin Lymphom 2018
14 Myocardial Changes in Childhood Cancer Patients Treated with Anthracyclines 2017
15 Clinicopathological pattern and outcome of pediatric malignant ovarian germ cell tumors: South Egypt Cancer Institute experience 2017
16 Clinicopathological pattern and outcome of pediatric malignant ovarian germ cell tumors: South Egypt Cancer Institute experience 2017
17 P-459 Myocardial Changes in Childhood Cancer Patients Treated with Anthracyclines 2017
18 Can Pediatric Risk of Mortality Score (PRISM III) Be Used Effectively in Initial Evaluation and Follow-up of Critically Ill Cancer Patients Admitted to Pediatric Oncology Intensive Care Unit (POICU)? A Prospective Study, in a Tertiary Cancer Center in Egy 2017
19 Myocardial Changes in Childhood Cancer Patients Treated with Anthracyclines 2017
20 Metronomic chemotherapy and radiotherapy as salvage treatment in refractory or relapsed pediatric solid tumours. 2016
21 The Outcome of Critically Ill Pediatric Cancer Patients Admitted to the Pediatric Intensive Care Unit in a Tertiary University Oncology Center in a Developing Country: A 5-Year Experience. 2016
22 Multimodality Treatment for Pediatric Nasopharyngeal Carcinoma: A Review of 24 patients in Upper Egypt. 2016
23 Metronomic chemotherapy and radiotherapy as salvage treatment in refractory or relapsed pediatric solid tumours. 2016
24 Metronomic chemotherapy and radiotherapy as salvage treatment in refractory or
relapsed pediatric solid tumours
2016
25 The Outcome of Critically Ill Pediatric Cancer Patients Admitted to the Pediatric Intensive Care Unit in a Tertiary University Oncology Center in a Developing Country: A 5-Year Experience. 2016
26 Pattern of Pediatric Tumors at Pediatric Department in South Egypt Cancer Institute 2016
27 Multimodality Treatment for Pediatric Nasopharyngeal Carcinoma: A Review of 24 patients in Upper Egypt. 2016
28 Castleman's Disease as a Rare Differential Diagnosis of Lymphadenopathy: 2 Case Reports and Review of Literature 2015
29 Pierre Marquet, Nicolas Picard Genetic variants in 6-mercaptopurine pathway as potential factors of hematological toxicity in acute lymphoblastic leukemia patients 2015
30 Clinicolaboratory Characteristics and Treatment Outcome of Pediatric Acute Lymphoblastic Leukemia at South Egypt Cancer Institute 2015
31 Outcome of Adolescents with Acute Lymphoblastic LeukemiaTreated by Pediatrics versus Adults Protocols 2014
32 • Risk-adapted Therapy of Pediatric Hodgkin Lymphoma in Upper Egypt 2014
33 Sacrococcygeal tumors: clinical characteristics and outcome of pediatric patients treated at South Egypt Cancer Institute. A retrospective analysis. 2013
34 Prognosis of early breast cancer by immunohistochemistry defined intrinsic sub-types in patients treated with adjuvant chemotherapy in the NEAT/BR9601 trial. 2013
35 Risk Stratification Treatment of Pediatric Rhabdomyosarcoma: South Egypt Cancer Institute experience 2012
36 Role of Surgery in Stages II and III Pediatric Abdominal Non-Hodgkin Lymphoma: A 5-Years Experience 2011
37 Risk-based combined-modality therapy of pediatric Hodgkin's lymphoma: A retrospective study 2010
38 Long-term Follow-up of Infantile Wilms Tumor Treated According to International Society of Pediatric Oncology Protocol: Seven Years' Follow-up 2010

1- Mahmoud Motaz Mohammed Ibrahim , Study of Cognitive Dysfunction in Patients with Acute Lymphoblastic Lukemia who Received CNS Prophylaxis ,2012-06-30
supervisor: Mohammed Hamdy Ghazaly, Amany Mohammed Ali, Heba Abdel Razik Sayed

2- Heba Hassan Husien Hassan , Pattern of Pediatric Solid Tumors in Pediatric Unite at Sohag Cancer Institute ,2012-06-30
supervisor: Mohammed Mahmoud Hamdy Ghazaly, Amany Mohammed Ali, Heba Abdel Razic Sayed

3- Salah Fargali Osman Ahmad , Assessment Of Child With Suspected Cancer ,2012-06-30
supervisor: Mohamed Hamdy Ghazaly, Amany Mohamed Ali, Heba Abde IRazik Sayed
 

الجمعيات العلمية و النقابات :